Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells.

Cuomo F, Coppola A, Botti C, Maione C, Forte A, Scisciola L, Liguori G, Caiafa I, Ursini MV, Galderisi U, Cipollaro M, Altucci L, Cobellis G.

Sci Rep. 2018 Apr 11;8(1):5842. doi: 10.1038/s41598-018-24221-5.

2.

Incontinentia Pigmenti.

Scheuerle AE, Ursini MV.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
1999 Jun 8 [updated 2017 Dec 21].

3.

The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.

Santoro A, Ciaglia E, Nicolin V, Pescatore A, Prota L, Capunzo M, Ursini MV, Nori SL, Bifulco M.

Inflamm Res. 2018 Apr;67(4):315-326. doi: 10.1007/s00011-017-1123-6. Epub 2017 Dec 11.

4.

Unusual Father-to-Daughter Transmission of Incontinentia Pigmenti Due to Mosaicism in IP Males.

Fusco F, Conte MI, Diociaiuti A, Bigoni S, Branda MF, Ferlini A, El Hachem M, Ursini MV.

Pediatrics. 2017 Sep;140(3). pii: e20162950. doi: 10.1542/peds.2016-2950. Epub 2017 Aug 9.

5.

New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases.

Müller K, Courtois G, Ursini MV, Schwaninger M.

Stroke. 2017 Feb;48(2):520-527. doi: 10.1161/STROKEAHA.116.012888. Epub 2017 Jan 12. Review. No abstract available.

PMID:
28082670
6.

NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II.

Pescatore A, Esposito E, Draber P, Walczak H, Ursini MV.

Cell Death Dis. 2016 Aug 25;7(8):e2346. doi: 10.1038/cddis.2016.245.

7.

Cognitive-behavioural phenotype in a group of girls from 1.2 to 12 years old with the Incontinentia Pigmenti syndrome: Recommendations for clinical management.

Pizzamiglio MR, Piccardi L, Bianchini F, Canzano L, Palermo L, Fusco F, D'Antuono G, Gelmini C, Garavelli L, Ursini MV.

Appl Neuropsychol Child. 2017 Oct-Dec;6(4):327-334. doi: 10.1080/21622965.2016.1188388. Epub 2016 Jun 7.

PMID:
27267212
8.

Targeted next-generation sequencing revealed MYD88 deficiency in a child with chronic yersiniosis and granulomatous lymphadenitis.

Giardino G, Gallo V, Somma D, Farrow EG, Thiffault I, D'Assante R, Donofrio V, Paciolla M, Ursini MV, Leonardi A, Saunders CJ, Pignata C.

J Allergy Clin Immunol. 2016 May;137(5):1591-1595.e4. doi: 10.1016/j.jaci.2015.09.050. Epub 2015 Nov 26. No abstract available.

PMID:
26632527
9.

Novel STAT1 gain-of-function mutation and suppurative infections.

Giardino G, Somma D, Cirillo E, Ruggiero G, Terrazzano G, Rubino V, Ursini MV, Vairo D, Badolato R, Carsetti R, Leonardi A, Puel A, Pignata C.

Pediatr Allergy Immunol. 2016 Mar;27(2):220-3. doi: 10.1111/pai.12496. Epub 2015 Dec 15. No abstract available.

PMID:
26467763
10.

B cells from nuclear factor kB essential modulator deficient patients fail to differentiate to antibody secreting cells in response to TLR9 ligand.

Giardino G, Cirillo E, Gallo V, Esposito T, Fusco F, Conte MI, Quinti I, Ursini MV, Carsetti R, Pignata C.

Clin Immunol. 2015 Dec;161(2):131-5. doi: 10.1016/j.clim.2015.08.008. Epub 2015 Aug 22.

PMID:
26307434
11.

EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.

Fusco F, Pescatore A, Conte MI, Mirabelli P, Paciolla M, Esposito E, Lioi MB, Ursini MV.

Int Rev Immunol. 2015;34(6):445-59. doi: 10.3109/08830185.2015.1055331. Epub 2015 Aug 13. Review.

PMID:
26269396
12.

COMMD7 as a novel NEMO interacting protein involved in the termination of NF-κB signaling.

Esposito E, Napolitano G, Pescatore A, Calculli G, Incoronato MR, Leonardi A, Ursini MV.

J Cell Physiol. 2016 Jan;231(1):152-61. doi: 10.1002/jcp.25066.

PMID:
26060140
13.

Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signaling.

Paciolla M, Pescatore A, Conte MI, Esposito E, Incoronato M, Lioi MB, Fusco F, Ursini MV.

Genes Immun. 2015 Jun;16(4):239-46. doi: 10.1038/gene.2015.3. Epub 2015 Mar 12. Review.

14.

Incontinentia pigmenti: report on data from 2000 to 2013.

Fusco F, Paciolla M, Conte MI, Pescatore A, Esposito E, Mirabelli P, Lioi MB, Ursini MV.

Orphanet J Rare Dis. 2014 Jun 24;9:93. doi: 10.1186/1750-1172-9-93.

15.

Incontinentia pigmenti: learning disabilities are a fundamental hallmark of the disease.

Pizzamiglio MR, Piccardi L, Bianchini F, Canzano L, Palermo L, Fusco F, D'Antuono G, Gelmini C, Garavelli L, Ursini MV.

PLoS One. 2014 Jan 29;9(1):e87771. doi: 10.1371/journal.pone.0087771. eCollection 2014.

16.

Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.

Conte MI, Pescatore A, Paciolla M, Esposito E, Miano MG, Lioi MB, McAleer MA, Giardino G, Pignata C, Irvine AD, Scheuerle AE, Royer G, Hadj-Rabia S, Bodemer C, Bonnefont JP, Munnich A, Smahi A, Steffann J, Fusco F, Ursini MV.

Hum Mutat. 2014 Feb;35(2):165-77. doi: 10.1002/humu.22483. Epub 2013 Dec 12.

PMID:
24339369
17.

Ontogenetic profile of innate immune related genes and their tissue-specific expression in brown trout, Salmo trutta (Linnaeus, 1758).

Cecchini S, Paciolla M, Biffali E, Borra M, Ursini MV, Lioi MB.

Fish Shellfish Immunol. 2013 Sep;35(3):988-92. doi: 10.1016/j.fsi.2013.05.026. Epub 2013 Jun 10.

PMID:
23765117
18.

Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans.

d'Alessio PA, Ostan R, Bisson JF, Schulzke JD, Ursini MV, Béné MC.

Life Sci. 2013 Jul 10;92(24-26):1151-6. doi: 10.1016/j.lfs.2013.04.013. Epub 2013 May 7.

PMID:
23665426
19.

The R156H variation in IL-12Rβ1 is not a mutation.

van de Vosse E, van Dissel JT, Palamaro L, Giardino G, Santamaria F, Romano R, Fusco A, Montella S, Salerno M, Ursini MV, Pignata C.

Ital J Pediatr. 2013 Feb 14;39:12. doi: 10.1186/1824-7288-39-12.

20.

A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX.

Poeta L, Fusco F, Drongitis D, Shoubridge C, Manganelli G, Filosa S, Paciolla M, Courtney M, Collombat P, Lioi MB, Gecz J, Ursini MV, Miano MG.

Am J Hum Genet. 2013 Jan 10;92(1):114-25. doi: 10.1016/j.ajhg.2012.11.008. Epub 2012 Dec 13.

Supplemental Content

Loading ...
Support Center